Optibiotix Health Share Discussion Threads

[scotty1] 30/8/2017 07:57

Primal he talks of multi £££;£££ markets,but the sales don't reflect getting any decent share of those markets,not yet anyway.

[parob] 30/8/2017 07:56

OptiBiotix results for the 6 months ended 31 May 2017 are set out in the Consolidated Statement of Comprehensive Income. Administrative expenses were GBP1,021,081 (GBP802,0823: 2016) including a number of NON-RECURRENT costs associated with the listing of SkinBiotherapeutics in April 2017.

[rollthedice] 30/8/2017 07:55

@john henry ~ cash dropped £1.6m+ in reported 6months period. Admin costs £1m in the same period. If cashburn has continued at same rate since end May (3mths) cash would be down a further £800k to £1.1m and by Xmas would be pretty much zero. Obviously I don't know what the actual cashburn has been since May but if reported figures are indicative the cashburn and need to raise more is pretty clear unless revenues have started coming in in volume.

[primal123] 30/8/2017 07:52

Scotty - how is SOH not walking the walk? He has done everything he has said so far.

[monkeywench1] 30/8/2017 07:51

I thought sales should be increasing?

[1marcr] 30/8/2017 07:50

I like this bit - Our teams have demonstrated that by combining our cholesterol reducing strain, LPLDL®, with galacto-oligosaccharides produced from it, we can selectively enhance its growth and increase cholesterol reduction threefold. Work in the last six months has extended these developments to other probiotic genera and species. To the best of our knowledge, this is the first time that anyone has developed an optimised synbiotic, or OptiBiotic®, that increases the growth and health benefit of a specific bacterium in the microbiome.

[scotty1] 30/8/2017 07:48

FailedQS are you reading the same results as me,because they don,t read that good to me.SOH certainly as the talk but he aint walking the walk yet imo.

[elrico] 30/8/2017 07:48

Cash was £3.15m at the last set of accounts before today's interims of £1.9m, which is inline with previously reported cash burn rate of £1.2m pa. Do the math, is not halved. The £4.1m on the books for the SBTX IPO is very likely to grow in value as well as the revenue streams.

[primal123] 30/8/2017 07:47

Rollthedice - as many have pointed out the SBTX issue has been handled badly but shares are not going to be given out until value increases in both companies, if they do give this now it could have an affect on the share prices. Also SOH has pointed out there is no need to raise cash. The cash burn is low so don't know where you are getting that.

[parob] 30/8/2017 07:46

OptiBiotix(R) currently have around a DOZEN formulations we are developing for partners covering cholesterol reduction, cardiovascular risk and broader concepts, such as healthy ageing.

[john henry] 30/8/2017 07:45

Rollthedice can you show calculations backing up your break even comment. Cash burn is tiny here.

[failedqs] 30/8/2017 07:39

Good set of results - should be a great deal of positive newsflow coming over the next few months as well.....
Glad to be in this one!

[rollthedice] 30/8/2017 07:39

Cash in hand almost halved to £1.9m, losses increased, revenues negligible (none of these unexpected), lots of positives on deals signed but will they need to raise cash before they can reach breakeven? They have choice of selling SBTX as well as equity raise or debt but shareholders were told they'd benefit from spin-off which hasn't to date materialised.

[primal123] 30/8/2017 07:36

I see Salim is speaking to himself again! How sad with his different usernames!

[primal123] 30/8/2017 07:33

The company has just started the commercial stage: "This period reflects the transition of OptiBiotix from a research and development company to a commercial business"

[runthejoules] 30/8/2017 07:31

Newb here = am I to read this as they still wouldn't be making a profit if they hadn't got £4.1m for IPOing Skinbiotix (as was)?

[joyjoy13] 30/8/2017 07:22

www.optibiotix-ir.com/content/investors/latest_results.asp

[shrewdmole] 30/8/2017 07:22

I like the final sentence - exciting and rewarding rest of 2017.

And the sugars sound like they are progressing well.

[john henry] 30/8/2017 07:20

Excellent very positive read.

[joyjoy13] 30/8/2017 07:19

It's in:-

OptiBiotix has made the following announcement:

Half Yearly Report

Please click on the following link to view it in full:
hxxp://www.optibiotix-ir.com/content/investors/latest_results.asp


This message is sent to you as a subscriber to the OptiBiotix News Alert Service.

If at any time you should wish to remove your name from the list please go to:
hxxp://www.optibiotix-ir.com/content/investors/alert.asp
enter your name, email address, check Unsubscribe is selected and press the Submit button.

[loveandmoney1] 30/8/2017 07:09

Harrods Premium Quality Jam.

[loveandmoney1] 30/8/2017 07:06

£1.9m in the bank

and losing 1m per year.

whats the market cap again?

LOL

[elrico] 29/8/2017 19:25

Slarty - Shorting is something I generally avoid because there is something morally repugnant about it, especially within the small cap arena where a company is trying to establish a commercial market and may need funds for the final push. I have only shorted 4 companies in 30+ years and ALL have been subject to fraudulent activities and to my mind, fair game. I accept there is an issue for investors, but to my mind they remain invested despite facts in the public domain and therefore subject to their own stupidity. As for shorting RANK, you know they are my employers biggest client, so this has another moral and professional implications for me. I am not going to get involved with the why's, wherefore and merits of going short.

Chin up fella, Chelski have found their mojo again. ;)